The Scientific Group, a leader in the IVD industry, and Inbiomotion, a company commercializing its proprietary MAF Test® for identifying high risk early-stage breast cancer patients have signed an ...
Breast cancer is the most common form of cancer among women, with more than 2 million new cases diagnosed each year. In cases where the tumor remains localized in the breast, survival rates are ...
HJ HyupJin, a Seoul-based South Korean healthcare and precision diagnostics company, and Inbiomotion, proprietors of MAF Test® for identifying high-risk early-stage breast cancer patients, have signed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results